Assessing Marijuana Use in Bariatric Surgery Candidates: Should It Be a Contraindication?

Obesity Surgery

Volumn 24, Issue 10, 2014, Pages 1764-1770

  Rummell, Christina M ^a   Heinberg, Leslie J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Bariatric surgery; Cannabis; Illicit drug use; Marijuana; Recommendations; Substance use disorder; Weight loss surgery

Indexed keywords

EID: 84939871610     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-014-1315-x     Document Type: Review

References (65)

1. Gastrointestinal surgery for severe obesity [reprint on the Internet]. Bethesda (MD): National Institutes of Health (US); NIH Consensus Development Conference Consensus Statement; 1991 Mar 25–27 [updated 2001 Oct 9; cited 2014 Jan 30]. Available from: http://consensus.nih.gov/1991/1991GISurgeryObesity084PDF.pdf
2. Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic Surgery. Surg Obes Relat Dis. 2013;9:159–91.
3. Saltzman E, Anderson W, Apovian CM, et al. Criteria for patient selection and multidisciplinary evaluation and treatment of the weight loss surgery patient. Obes Res. 2005;13:234–43.
4. Heinberg LJ, Ashton KA, Coughlin J. Alcohol and bariatric surgery: review and suggested recommendations for assessment and management. Surg Obes Relat Dis. 2012;8:357–63.
5. Ertelt TW, Mitchell JE, Lancaster K, et al. Alcohol abuse and dependence before and after bariatric surgery: a review of the literature and report of a new data set. Surg Obes Relat Dis. 2008;4:647–50.
6. Steffen KJ, Engel SG, Pollert GA, et al. Blood alcohol concentrations rise rapidly and dramatically after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2013;9:470–3.
7. Woodward GA, Downey J, Hernandez-Boussard T, et al. Impaired alcohol metabolism after gastric bypass surgery: a case-crossover trial. J Am Coll Surg. 2011;212:209–14.
8. King WC. Prevalence of alcohol use disorders before and after bariatric surgery. J Am Med Assoc. 2012;307:2515–25.
9. Svensson P, Anveden A, Romeo S, et al. Alcohol consumption and alcohol problems after bariatric surgery in the Swedish Obese Subjects study. Obesity. 2013;21:2444–51.
10. Lautz DB, Jackson TD, Clancy KA, et al. Bariatric operations in Veterans Affairs and selected university medical centers: results of the patient safety in surgery study. J Am Coll Surg. 2007;204:1261–72.
11. Egred M, Davis GK. Cocaine and the heart. Postgrad Med J. 2005;81:568–71.
12. Choi JY, Scarborough TK. Stroke and seizure following a recent laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2004;14:857–60.
13. DrugFacts: marijuana [Internet]. Rockville (MD): National Institute on Drug Abuse (US), National Institutes of Health; 2012 [cited 2013 Dec 9]. Available from: http://www.drugabuse.gov/publications/drugfacts/marijuana.
14. Hudak J. 2014, a make or break year for legal pot [Internet]. Washington DC: CNN Opinion; 2013 Dec 30 [cited 2014 Jan 30] Available from: http://www.cnn.com/2013/12/30/opinion/hudak-marijuana-2014/.
15. Gurley RJ, Aranow R, Katz M. Medical marijuana: a comprehensive review. J Psychoactive Drugs. 1998;30:137–47.
16. Merriman AR, Oliak DA. Use of medical marijuana for treatment of severe intractable nausea after laparoscopic Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2008;4:550–1.
17. Rosenthal MS, Kleber HD. Making sense of medical marijuana. Proc Assoc Am Physicians. 1999;2:159–65.
18. Heinberg LJ, Askton KA, Windover A. Moving beyond dichotomous psychological evaluation: the Cleveland Clinic Behavioral Health Rating System for weight loss surgery. Surg Obes Relat Dis. 2010;6:185–90.
19. Petry NM, Barry D, Pietrzak RH, et al. Overweight and obesity are associated with psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. Psychosom Med. 2008;70:288–97.
20. Tarescavage AM, Windover A, Ben-Porath YS, et al. Use of the MMPI-2-RF suicidal/death ideation and substance abuse scales in screening bariatric surgery candidates. Psychol Assess. 2013;25:1–6.
21. Degenhardt L, Coffey C, Carlin JB, et al. Are diagnostic orphans at risk of developing cannabis abuse or dependence? Four-year follow-up of young adult cannabis users not meeting diagnostic criteria. Drug Alcohol Depend. 2008;92:86–90.
22. Alexander D, The LP, DSM. Guided Cannabis Screen (DSM-G-CS): description, reliability, factor structure and empirical scoring with a clinical sample. Addict Behav. 2011;36:1095–100.
23. Bauchowitz AU, Gonder-Frederick LA, Oblrisch M, et al. Psychosocial evaluation of bariatric surgery candidates: a survey of present practices. Psychosom Med. 2005;67:825–32.
24. Clark MM, Balsiger BM, Sletten CD, et al. Psychosocial factors and 2-year outcome following bariatric surgery for weight loss. Obes Surg. 2003;13:739–45.
25. Tsuda S, Barrios L, Schneider B, et al. Factors affecting rejection of bariatric patients from an academic weight loss program. Surg Obes Relat Dis. 2009;5:199–202.
26. National Institute on Drug Abuse (US). Marijuana abuse [Internet]. Rockville (MD): National Institutes of Health (US); 2012 July. 12 p. Publication No.: 12-3859.
27. Allsop DJ, Norberg MM, Copeland J, et al. The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress. Drug Alcohol Depend. 2011;119:123–9.
28. Respiratory effects of marijuana [Internet]. Seattle (WA): University of Washington Alcohol and Drug Abuse Institute (US); 2013 Aug [cited 2013 Dec 9]. Available from: http://adai.washington.edu/marijuana/factsheets/respiratoryeffects.pdf.
29. Tetrault JM, Crothers K, Moore BA, et al. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med. 2007;167:221–8.
30. Aharonovich E, Liu X, Samet S, et al. Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study. Am J Psychiatry. 2005;162:1507–14.
31. Callaghan RC, Allebeck P, Sidorchuk A. Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control. 2013;10:1811–20.
32. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009;374:1383–91.
33. Battistella G, Fornari E, Annoni JM et al. Long-term effects of cannabis on brain structure. Neuropsychopharmacology 2014: 1-8.
34. Patton GC, Coffey C, Carlin JB, et al. Cannabis use and mental health in young people: cohort study. BMJ. 2002;325:1195–8.
35. 20 legal medical marijuana states and DC [Internet]. Santa Monica (CA): Procon.org (US); 2013 Dec 13 [cited 2014 Jan 30]. Available from: http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881.
36. Schauer PS, Chand B, Brethauer S et al. Bariatric and Metabolic Institute (BMI) patient handbook. 2011 Feb. 48 leaves. Located at Bariatric and Metabolic Institute, Cleveland Clinic Foundation, Cleveland, OH.
37. Kalarchian MA, Marcus MD, Levine MD, et al. Psychiatric disorders among bariatric surgery candidates: relationship to obesity and functional health status. Am J Psychiatry. 2007;164:328–34.
38. Sarwer DB, Cohn NI, Gibbons LM, et al. Psychiatric diagnoses and psychiatric treatment among bariatric surgery candidates. Obes Surg. 2004;14:1148–56.
39. Buffington CK. Alcohol use and health risks: survey results. Bariatric Times. 2007;4:21–3.
40. Black DW, Goldstein RB, Mason EE. Prevalence of mental disorder in 88 morbidly obese bariatric clinic patients. Am J Psychiatry. 1999;149:227–34.
41. Mitchell JE, Steffen KJ, de Zwaan M, et al. Congruence between clinical and research-based psychiatric assessment in bariatric surgical candidates. Surg Obes Relat Dis. 2010;6:628–34.
42. Stinson FS, Ruan WJ, Pickering R, et al. Cannabis use disorders in the USA: prevalence, correlates, and co-morbidity. Psychol Med. 2006;10:1447–60.
43. American Psychiatric Association. Diagnostic and statistical manual of mental disorders-IV. Washington: American Psychiatric Association; 2000.
44. Substance-related and addictive disorders [Internet]. Washington DC: American Psychiatric Publishing, American Psychiatric Association; 2013 [cited 2014 Jan 9]. Available from: http://www.dsm5.org/Documents/Substance%20Use%20Disorder%20Fact%20Sheet.pdf.
45. Heinberg LJ, Ashton K. History of substance abuse relates to improved postbariatric body mass index outcomes. Surg Obes Relat Dis. 2010;6:417–22.
46. Livingston EH. Obesity, psychological testing and substance abuse. Surg Obes Relat Dis. 2006;2:312.
47. Warren M, Frost-Pineda K, Gold M. Body mass index and marijuana use. J Addict Dis. 2005;24:95–100.
48. Brethauer S, Chand B, Schauer PR. Risks and benefits of bariatric surgery: current evidence. Cleve Clin J of Med. 2006;73:993–1007.
49. Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev. 2010;1:45–50.
50. Berridge KC, Ho C, Richard JM, Di Feliceantonio AG. The tempted brain eats: pleasure and desire circuits in obesity and eating disorders. Brain Res. 2010;1350:43–64.
51. Barry D, Clarke M, Petry NM. Obesity and its relationship to addictions: is overeating a form of addictive behavior? Am J Addict. 2008;18:439–51.
52. Le Foll B, Trigo JM, Sharkey KA, et al. Cannabis and ∆9-tetrahydrocannabinol (THC) for weight loss? Med Hypotheses. 2013;80:564–7.
53. Sogg S. Alcohol misuse after bariatric surgery: epiphenomenon or “Oprah” phenomenon? Surg Obes Relat Dis. 2007;3:366–8.
54. Kruseman M, Leimgruber A, Zumbach F, et al. Dietary, weight, and psychological chances among patients with obesity, 8 years after gastric bypass. J Am Diet Assoc. 2010;110:527–34.
55. Warren MW, Gold MS. The relationship between obesity and drug use. Am J Psychiatry. 2007;164:1268–68.
56. King WC, Chen JY, Mitchell JE, et al. Prevalence of alcohol use disorders before and after bariatric surgery. JAMA. 2012;307:2516–25.
57. Herpertz S, Kielmann R, Wolf AM, et al. Do psychosocial variables predict weight loss or mental health after obesity surgery? A systematic review. Obes Res. 2004;12:1554–69.
58. Corsica JA, Pelchat ML. Food addiction: true or false? Curr Opin Gastroenterol. 2010;2:165–9.
59. Avena NM, Gold MS. Food and addiction—sugars, fats and hedonic overeating. Addiction. 2011;106:1214–5.
60. Gearhardt AN, Corbin WR, Brownell KD. Preliminary validation of the Yale Food Addiction Scale. Appetite. 2009;52:430–6.
61. Webb WW, Morey LC, Castelnuovo-Tedesco P, et al. Heterogeneity of personality traits in massive obesity and outcome prediction of bariatric surgery. Int J Obes. 1990;14:13–20.
62. Copeland J, Gilmour S, Gates P, et al. The Cannabis Problems Questionnaire: factor structure, reliability, and validity. Drug Alcohol Depend. 2005;80:313–9.
63. Bashford J, Flett R, Copeland J. The Cannabis Use Problems Identification Test (CUPIT): development, reliability, concurrent and predictive validity among adolescents and adults. Addiction. 2010;105:615–25.
64. Merrell J, Ashton K, Windover A, et al. Psychological risk may influence drop-out prior to bariatric surgery. Surg Obes Relat Dis. 2012;8:463–9.
65. Batulla A, Garcia-Rizo C, Castellví P, et al. Screening for substance use disorders in first-episode psychosis: implications for readmission. Schizophr Res. 2013;146:125–31.